Locus | SNP | Gout risk allele | All participants (N = 458,367) | Men (N = 209,493) | Women (N = 248,874) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Obs, % | IT (OR) | 95% CI | P-value | Obs, % | IT (OR) | 95% CI | P-value | Obs, % | IT (OR) | 95% CI | P-value | |||
GCKR | rs1260326 | T | 76.4% | 1.000 | 0.998, 1.002 | 0.80 | 80.0% | 1.000 | 0.998, 1.002 | 0.78 | 73.3% | 0.996 | 0.984, 1.008 | 0.51 |
ADH1B | rs1229984 | T | 76.4% | 1.012 | 1.008, 1.016 | 8.15 × 10−9 | 80.0% | 1.011 | 1.007, 1.016 | 6.07 × 10−8 | 73.3% | 1.027 | 1.006, 1.048 | 0.01 |
MLXIPL | rs6460047 | T | 76.0% | 0.999 | 0.994, 1.003 | 0.60 | 79.6% | 0.999 | 0.994, 1.004 | 0.68 | 72.9% | 0.983 | 0.959, 1.008 | 0.18 |
NFAT5 | rs113441031 | T | 75.8% | 0.998 | 0.997, 1.000 | 0.08 | 79.5% | 0.998 | 0.997, 1.000 | 0.09 | 72.8% | 1.000 | 0.987, 1.013 | 0.99 |